Campbell & CO Investment Adviser LLC

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1353570 BALTIMORE, MD

Position in BMRN

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$1,350,563

-$3,759,228 QoQ

Shares Held

23,603

-72.5% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#243

of 561 holders

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Campbell & CO Investment Adviser LLC holds $72,173,828 across 47 Biotechnology names. BMRN ranks #19 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	9,899	$6,172,422
2	CRSP	CRISPR Therapeutics AG	107,529	$5,864,631
3	CYTK	Cytokinetics Inc	65,978	$5,620,665
4	INSM	INSMED Inc	43,856	$4,675,926
5	IONS	Ionis Pharmaceuticals Inc	49,632	$3,935,321
6	HALO	Halozyme Therapeutics, Inc.	44,702	$3,498,825
7	ALNY	Alnylam Pharmaceuticals, Inc.	11,183	$3,366,418
8	RPRX	Royalty Pharma plc	52,688	$2,954,216

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,350,563	23,603	-72.5%	Shares	Sole	2026-08-03
2025-12-31	$5,109,791	85,980	+372.1%	Shares	Sole	2026-02-12
2025-09-30	$986,416	18,213	-75.6%	Shares	Sole	2025-10-28
2025-06-30	$4,097,958	74,549	+465.4%	Shares	Sole	2025-08-07
2024-06-30	$1,085,603	13,186	-58.9%	Shares	Sole	2024-08-13
2024-03-31	$2,804,487	32,110	+803.5%	Shares	Sole	2024-05-10
2023-12-31	$342,676	3,554	+5.6%	Shares	Sole	2024-02-13
2023-06-30	$291,678	3,365	-72.9%	Shares	Sole	2023-08-11
2022-12-31	$1,283,793	12,405	+178.8%	Shares	Sole	2023-02-14
2022-09-30	$377,226	4,450	-62.0%	Shares	Sole	2022-11-14
2022-06-30	$971,650	11,725	+97.1%	Shares	Sole	2022-08-09
2021-12-31	$525,682	5,950	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.